Numerai’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,884
Closed -$770K 402
2024
Q3
$770K Sell
14,884
-3,832
-20% -$180K 0.21% 159
2024
Q2
$777K Buy
+18,716
New +$837K 0.28% 117
2024
Q1
Sell
-14,544
Closed -$746K 259
2023
Q4
$746K Buy
+14,544
New +$763K 0.26% 115

Other funds holding BMY

Numerai's BMY Position: Q4 2024 in Review

Numerai sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 14,884 shares — an estimated $770K sold.

Numerai first reported a position in BMY in Q4 2023 and held it in 3 quarters. The position peaked at $777K in Q2 2024. 2,493 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • Numerai reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
  • Numerai sold 14,884 Bristol-Myers Squibb shares in Q4 2024, an estimated $770K.
  • Numerai first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 3 quarters.
  • Numerai's Bristol-Myers Squibb position peaked at $777K in Q2 2024.
  • 2,493 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Numerai's 13F filing for Q4 2024, filed 14 Feb 2025.